Correlation Between Merrimack Pharmaceuticals and OPTHEA
Can any of the company-specific risk be diversified away by investing in both Merrimack Pharmaceuticals and OPTHEA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merrimack Pharmaceuticals and OPTHEA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Merrimack Pharmaceuticals and OPTHEA LTD, you can compare the effects of market volatilities on Merrimack Pharmaceuticals and OPTHEA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merrimack Pharmaceuticals with a short position of OPTHEA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merrimack Pharmaceuticals and OPTHEA.
Diversification Opportunities for Merrimack Pharmaceuticals and OPTHEA
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Merrimack and OPTHEA is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Merrimack Pharmaceuticals and OPTHEA LTD in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OPTHEA LTD and Merrimack Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merrimack Pharmaceuticals are associated (or correlated) with OPTHEA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OPTHEA LTD has no effect on the direction of Merrimack Pharmaceuticals i.e., Merrimack Pharmaceuticals and OPTHEA go up and down completely randomly.
Pair Corralation between Merrimack Pharmaceuticals and OPTHEA
If you would invest 341.00 in OPTHEA LTD on May 5, 2025 and sell it today you would earn a total of 0.00 from holding OPTHEA LTD or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Merrimack Pharmaceuticals vs. OPTHEA LTD
Performance |
Timeline |
Merrimack Pharmaceuticals |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
OPTHEA LTD |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Merrimack Pharmaceuticals and OPTHEA Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Merrimack Pharmaceuticals and OPTHEA
The main advantage of trading using opposite Merrimack Pharmaceuticals and OPTHEA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merrimack Pharmaceuticals position performs unexpectedly, OPTHEA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OPTHEA will offset losses from the drop in OPTHEA's long position.Merrimack Pharmaceuticals vs. Amicus Therapeutics | Merrimack Pharmaceuticals vs. Celldex Therapeutics | Merrimack Pharmaceuticals vs. Puma Biotechnology | Merrimack Pharmaceuticals vs. Agios Pharm |
OPTHEA vs. Aligos Therapeutics | OPTHEA vs. Anebulo Pharmaceuticals | OPTHEA vs. Climb Bio | OPTHEA vs. Janux Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |